Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
February 12, 2021

Coronavirus company news summary – WHO approves AstraZeneca/Oxford vaccine in all adults – US procures more doses of Moderna’s vaccine

By Allie Nawrat

12 February 2021 

A World Health Organization (WHO) panel has recommended that the Covid-19 vaccine developed by AstraZeneca and the University of Oxford can be used for widespread use, including in people aged over 65. Interim recommendations suggested that the vaccine be taken in two does, with a gap of of eight to 12 weeks between doses. South Africa had recently paused its rollout as a result of inefficacy data from a trial of the vaccine in the South African (501Y.V2) variant.

The US government has procured an additional 100 million doses of Moderna’s Covid-19 vaccine, bringing the total confirmed order to 300 million doses. The company has supplied 41 million doses of the vaccine to the US to date.

Related Companies

Content from our partners
Extractables and leachables analysis in pharmaceutical quality control
How Hengst helped to keep Germany’s charity “star singers” shining
Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU